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Abstract
Background: Chromosomal abnormalities affecting human chromosome 15q11-q13 underlie
multiple genomic disorders caused by deletion, duplication and triplication of intervals in this
region. These events are mediated by highly homologous segments of DNA, or duplicons, that
facilitate mispairing and unequal cross-over in meiosis. The gene encoding an amyloid precursor
protein-binding protein (APBA2) was previously mapped to the distal portion of the interval
commonly deleted in Prader-Willi and Angelman syndromes and duplicated in cases of autism.
Results: We show that this gene actually maps to a more telomeric location and is partially
duplicated within the broader region. Two highly homologous copies of an interval containing a
large 5' exon and downstream sequence are located ~5 Mb distal to the intact locus. The duplicated
copies, containing the first coding exon of APBA2, can be distinguished by single nucleotide
sequence differences and are transcriptionally inactive. Adjacent to APBA2 maps a gene termed
KIAA0574. The protein encoded by this gene is weakly homologous to a protein termed X123 that
in turn maps adjacent to APBA1 on 9q21.12; APBA1 is highly homologous to APBA2 in the C-terminal
region and is distinguished from APBA2 by the N-terminal region encoded by this duplicated exon.
Conclusion: The duplication of APBA2 sequences in this region adds to a complex picture of
different low copy repeats present across this region and elsewhere on the chromosome.
Background
Human chromosome 15q11-q13 is associated with ge-
nomic disorders involving deletions, duplications and
triplications of different intervals in this region. The for-
mation of these cytogenetic abnormalities is mediated by
low-copy repeated sequences, or duplicons [1]. High se-
quence homology between copies presumably facilitates
mispairing and unequal recombination events in meiosis.
Interstitial deletion of 15q11-q13 results in Prader-Willi
syndrome (PWS; MIM # 176270) or Angelman syndrome
(AS; MIM # 105830), when deletions occur on the pater-
nally-derived or maternally-derived homolog, respective-
ly (see Figure 1; reviewed in refs. [2–4]). Interstitial
duplication of the same interval has been found in cases
of autism, and data suggest a higher risk for autism with
maternal compared to paternal duplications [5–7]. Chro-
mosome 15 is the most frequently involved chromosome
in cases of autism with supernumerary marker
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cated and pseudodicentric structures and are known as inv
dup(15) or idic(15). Small markers which do not contain
the PWS/AS deletion interval are associated with a normal
phenotype [8]. Larger idic(15) duplications are typically
associated with a more severe autistic phenotype than that
seen in cases of interstitial duplication [5–7,9–12]. The in-
creased severity may be due to the presence of two addi-
tional copies of this region, however these duplications
also extend significantly farther telomerically and there-
fore contain more duplicated genes. ldic(15) markers also
vary in the location of the distal breakpoint, depending on
which duplicon sequence mediated the rearrangement.
Interstitial triplications have also been described, and
these tend to utilize variable distal breakpoints common
to idic(15) chromosomes [13]. Triplications are associat-
ed with a phenotype analogous to that for idic(15) when
maternally-derived [7,12,13].
Several functional duplicons have been described, and
these may be divided into two classes. There are two prox-
imal breakpoints (BP1 and BP2) that define two classes of
PWS/AS deletion [14]. The common distal breakpoint is
termed BP3 and has a bipartite structure [15,16]. The BP2
and BP3 duplicons span several hundred kb and contain
at least seven expressed sequences. One prominent exam-
ple is the HERC2 (Hect domain and Rcc1 domain protein
2) gene [17]. Approximately 11 HERC2 copies have been
identified on chromosomes 15 and 16, although most
map to 15q11-q13. Another class of 15q duplicons has
been termed LCR15s, for low copy repeats [18,19]. These
share some sequences in common with the large HERC2
duplicons. LCR15s extend only ~15 kb individually, but
are often present in clusters extending to 30–60 kb. This
class of duplicon has been proposed to help mediate rear-
rangements in idic(15) markers and larger interstitial du-
plications and triplications [19].
The gene encoding the amyloid precursor protein-binding
protein A2 (APBA2) was previously mapped to chromo-
some 15 [20] and localized to the common PWS/AS dele-
tion region centromeric to BP3 and distal to a cluster of
GABAA receptor subunit genes [21,22] (see Figure 1). This
location made APBA2 an attractive positional candidate
gene for involvement in duplication-associated and inher-
ited autism. On this basis we sought to characterize
APBA2 in terms of structure and expression. APBA2 has
also been termed Mint2, for Munc-interacting protein 2,
or X-11β. Mint2 functions as a neuronal adaptor protein
that binds to the Munc18-1 protein, which is essential for
synaptic vesicle exocytosis [23]. Biederer and Südhof have
shown that a multiprotein complex containing Mint1
(APBA1) binds to the cytoplasmic tail of neurexins, which
play a critical role in synaptic vesicle exocytosis. Mint1
and Mint2 can bind directly to neurexins via a PDZ do-
main-mediated interaction. Thus the Mint proteins serve
to anchor Munc-18 to the neurexins and thereby facilitate
exocytosis. We show here that APBA2 actually maps to a
more distal location, outside the narrow common intersti-
tial deletion/duplication interval but within the larger id-
ic(15) duplications. We found that a large 5' and the first
coding exon of APBA2 is duplicated, and these transcrip-
tionally inactive copies are located at more telomeric sites
within the region. The nature of the duplication may have
implications for the evolution of APBA2/Mint2 from its
other family members.
Figure 1
Schematic representation of 15q11-q13. The chromosome 15q11-q13 is depicted, with breakpoints utilized in PWS/AS 
deletions and autism-associated duplications and triplications represented by larger jagged lines. Smaller jagged lines identify 
rare chromosomal breakpoints which delimit the PWS and AS critical regions. Centromeric (cen) and telomeric (tel) orienta-
tion is shown and breakpoints are numbered from BP1-BP5. Arrows over the map show the intervals deleted in PWS/AS and 
duplicated in duplications or triplications affecting 15q11-q13. Gene and framework marker positions are indicated over the 
map. The most narrow autism candidate region is based on the smallest autism-associated maternally-biased duplications.
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We sought to characterize the structure and expression of
the APBA2 gene, as a prelude to analysis of this gene as a
possible autism candidate. We obtained a bacterial artifi-
cial chromosome (BAC) clone (686I6) containing ge-
nomic sequence of the APBA2 transcriptional unit. We
also obtained yeast artificial chromosome (YAC) clones
covering the interval between the 3' end of GABRG3 and
OCA2 (962D11; contig WC-153) and to which an APBA2
EST (Wl-14097) and nearby markers had been mapped
(764C6; contig WC-699). STS content mapping demon-
strated that APBA2 sequences and other markers are
present within the BAC 686I6 and YAC 764C4 but absent
from the YAC clone covering the GABRG3-OCA2 interval
(Figure 2b). Thus, the previous map position appeared to
be incorrect. Based on STS marker content in the 68616
clone, APBA2 maps to a more distal location in 15q13.
The revised map position places APBA2 outside of the
most narrow interstitial duplication interval and the area
most supported by linkage data but within the larger id-
ic(15) duplications. Current genomic sequence assem-
blies now agree with this experimentally-determined data.
To facilitate direct screening of APBA2, we determined the
gene structure and developed exon-specific PCR assays.
We characterized genomic structure using a combination
of existing genomic sequence and direct sequencing from
BAC clone template. APBA2 is encoded by 14 exons; 12
exons are coding and 2 exons contain 5' untranslated se-
quence. All exons are now accurately predicted in the
NCBI (Genbank: NT_010363) and Celera assemblies,
while the EnsembI assembly lacks the putative first exon.
A sequence containing this exon has been deposited in
GenBank (accession: AY228760). Junctions for most ex-
ons were confirmed by direct sequencing from RP-11 BAC
330K3 template, which also contains the APBA2 transcrip-
tional unit. Table 1 itemizes intron-exon boundary infor-
mation. Primer sequences and conditions for PCR
amplification of coding exons (3–14) are presented in Ta-
ble 2. APBA2 is transcribed towards the telomere.
In the course of analyzing the structure of APBA2, we not-
ed that a large 5' exon containing the initiating methio-
nine codon was present not only in the 686I6 BAC but
also highly homologous to sequences from other BAC
clones with non-overlapping STS content. In silico STS
content mapping revealed two distinct pairs of BAC
clones containing the partial duplications (Figure 2a).
One of these (RP-11 clones 602M11 and 122P18) also
contains a partial duplication of a pseudogene containing
the 3' end of the neuronal nicotinic receptor α 7 subunit
(CHRNA7) gene [24]. This pseudogene locus maps to a
site telomeric to APBA2 in 15q13. The second group of
BACs (RP-11 438P7 and 1 H8) contained the partial
APBA2 duplication and the K+CI- cotransporter (SLC12A6
or KCC3) gene. The duplications include the entire 1-kb
exon and ~5-kb of downstream sequence, however this se-
quence is interrupted in the intact locus by an ~9.7-kb
non-duplicated interval. The first block of homology in-
cludes exon 3, ~100 bp of sequence 5' and 1,045 bp 3' to
the exon. Following the homology gap, there is an addi-
tional 3,945 bp of duplicated sequence. Furthermore, an
additional 15 kb region in both sets of BACs containing
partial APBA2 duplications is highly homologous to a re-
gion approximately 25 kb upstream of the presumptive
first exon of APBA2. Current sequence assemblies show
the correct map location for the intact locus and show the
map location of these dupAPBA2 sequences at ~5 Mb
telomeric.
BLAST analysis of BACS containing the partial APBA2 du-
plications revealed duplicon-like sequences, based on sig-
nificant homology to a large number of BACs from known
duplicons. The largest number of similarities detected
(>30) corresponds to an interval of ~15 kb located ~15 kb
centromeric to the APBA2 duplications. However, there is
highly significant homology over ~100-kb of sequence
from assembly contig NT_035325 mapping to 15q26,
where LCR-15 duplicon sequences have been reported
[18]. These sequences appear to correspond to the LCR15
class of duplicons, based on sequence content. BLAST
analysis of sequence at the intact locus revealed a similar
low copy repeat or duplicon-type sequence of ~1.3-kb.
More than 80 copies of this sequence are present at sites
across the genome on every chromosome, and with an ap-
parent clustering at telomere locations. This sequence,
while short, does not correspond to any of the known
chromosome 15q11-q13 duplicon sequences, and there-
fore could represent a novel class of such low copy re-
peats. This sequence has been deposited in GenBank
(AY237156). It is worth noting that the presence of mul-
tiple duplicons and repeated sequences has significantly
complicated genomic sequence assembly for this region.
Since the partial duplications of APBA2 contained the first
coding exon and the transcription start site(s) for APBA2
have not been characterized, we sought to determine
whether these copies were transcriptionally active. We de-
veloped restriction fragment length polymorphism
(RFLP) assays to detect sequence differences
discriminating the intact APBA2 locus from the partial du-
plications. These assays were used following PCR from ge-
nomic or BAC DNA and cDNA from adult and fetal
human brain (Figure 2c). Distinct "fingerprint" patterns
are apparent for the intact locus and the duplications. The
sequence differences used in Figure 2c that distinguish the
duplications from the intact locus do not distinguish the
duplications from each other. This distinction was made
based on in silico analysis of numerous sequence differ-
ences, clone-sequence assembly and clone-marker/genePage 3 of 11
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BMC Genomics 2003, 4 http://www.biomedcentral.com/1471-2164/4/15content relationships. The pattern in cDNA samples was
identical to that in clone 686I6 but not either of the two
duplications. These data argue that the only transcript
present in brain corresponds to the intact locus, and that
the two partial duplications are therefore not transcribed.
Immediately telomeric to APBA2 lies another gene
(KIAA0574; see Figure 2a), which was initially identified
from a sequencing project of large, brain-derived cDNAs
[25]. KIAA0574 encodes a protein of unknown function,
and is transcribed in the opposite orientation relative to
APBA2. BLASTP using the KIAA0574 predicted amino acid
Figure 2
Physical mapping of APBA2 and PCR-RFLP analysis of APBA2 duplications. A. An expanded view of the 15q12-q14 
region containing distal duplication breakpoints is shown. Breakpoints BP3 and BP5 are depicted as jagged, hatched structures; 
BP4 is not thus shown but its position is indicated by an arrow over the map. STS marker positions are indicated on the map 
by closed circles, and arrows over the map indicate transcriptional orientation for genes in this region. YAC and BAC clone 
locations are shown below the map; YAC 764C6 is located in contig WC-153 and 962D11 is in WC-699. Closed circles within 
clones reflects the inclusion and position of specific STS markers shown above. B. PCR amplification of an APBA2-specific STS 
using genomic, YAC and BAC templates is shown. Position of clone pairs relative to cytogenetic banding and public sequence 
assemblies is indicated. Product consistent with genomic template is present only in clones from the region just telomeric to 
BP3. C. PCR from genomic or BAC clone template, followed by restriction with either Hinfl or Avall is shown. Unique banding 
patterns, corresponding to single nucleotide differences between copies, may be observed for the intact locus and each of the 
two duplication copies. RT-PCR using adult or fetal cDNA reveals the pattern corresponding to the intact locus only.
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BMC Genomics 2003, 4 http://www.biomedcentral.com/1471-2164/4/15sequence detects weak homology (35% identity, 64%
similarity over 69 residues) to a protein termed X123, the
gene for which is located in the 9q12.21 Freidrich's ataxia
region. The X123 gene in turn maps immediately adjacent
to APBA1 (alias Mint1 or X11α). APBA1 and APBA2 are
highly homologous for the C-terminal half of their respec-
tive sequences (90% similar, 84% identical). The N-termi-
nal half, corresponding to the duplicated exon, is only
weakly similar (36% similar, 30% identical). Thus the dis-
tinction between the APBA1 and APBA2 proteins corre-
sponds to exon 3-encoded residues. Despite the
comparatively weak homology between the KIAA0574
and X123 predicted peptides, this scenario suggests a clear
evolutionary relationship between these gene pairs. The
propensity of the 15q11-q13 region to undergo rearrange-
ment may have played a role in the evolution of this gene
family.
The distribution of APBA2 brain expression was deter-
mined using in situ hybridization and northern blotting.
Commercial brain northern blots were hybridized with a
cDNA probe corresponding to exon 3. Such a probe al-
lows us to discriminate between APBA2 expression and
potential signal from APBA1. Northern blotting revealed a
predominant moderate-abundance transcript of ~4.2-kb
widely distributed throughout the brain and spinal cord
(Figure 3a). Several smaller transcripts were also seen. A
cDNA clone for the mouse ortholog of APBA2 was ob-
tained and a similar probe was used to test for expression
using in situ hybridization to mouse brain sections. Figure
3b shows representative coronal and sagittal mouse brain
sections. Apba2 demonstrates moderate expression in
mouse cortical and limbic regions including frontal, pari-
etal, and temporal cortex, hippocampus, amygdala, thala-
mus, and cerebellum and lower level expression in many
other regions summarized in Table 3. A developmental
expression series illustrating expression from embryonic
day 8 through day 15 (E8-E15) is shown in Figure 4. Early
expression in the primitive neural tube emerges at day
E10. Apba2 expression extends throughout the neural tube
during days E11 and E12, but is apparently restricted to
the primitive brain vesicles during days E13 and E14.
Within the brain, distribution is ubiquitous and uniform.
In addition to diffuse expression throughout the brain, by
day E15, a punctate pattern appears around the spinal
Table 1: APBA2 intron-exon junctions
Exon Exon Size 
(bp)
3' splice acceptor-5' splice donor* Intron 
Size (kb)
1 117 TTT ACA ... TTC TGA /gtgatg >74
2 53 ttccag/ AAA GAT TTT TAG /gtaaga 58
3 990 ccacag/ TGG CTG ... GAG CAG /gtagga 20.3
Glu Gln
4 80 ttccag/ GTT TGC ... CCA GAG /gtaatt 1.1
Val Cys Pro Glu
5 36 taacag/ ACA AAG ... GTG GCT G /gtaagt 17
Thr Lys Val Ala Val
6 145 cttcag/ TT CCA GGG ... GTC AAG /gtagag 1.1
Val Pro Gly Val Lys
7 35 tgtcag/ AGG ATG ... AAA GCG /gtgtgt 4.2
Arg Met Lys Ala
8 86 tcttag/ AAT TCT ... ACG CAG /gtaagc 3
Asn Ser Thr Gln
9 185 cgacag/ GAA ACC ... GAG GAT /gtaagt 3.6
Glu Thr Glu Asp
10 179 gcacag/ GCC CAG ... AAG GAG /gtaagc 1
Ala Gin Lys Glu
11 212 ttgcag/ CTG CAG ... ATC AAG /gtaggc 1.5
Leu Gin ISO Lys
12 119 ctgcag/ GGC CTG ... GGA ATT /gtgagt 5.5
Gly Leu Gly ISO
13 140 gcttag/ ATC TGC ... GGA GAG /gtaagg 3
ISO Cys Gly Glu
14 1257 ccgcag/ ATC CAC ...
ISO His
*Intron and exon sequences are shown in lower-case and upper-case, respectively, with encoded amino acids indicated below the relevant codon.Page 5 of 11
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BMC Genomics 2003, 4 http://www.biomedcentral.com/1471-2164/4/15Figure 3
Expression analysis of APBA2/Apba2. A. Northern blot analysis of APBA2 in human brain. B. Relative expression of Mint2 
in adult mouse brain by in situ hybridization. Mint2 shows highest expression in cortical and limbic regions, including limbic 
nuclei of the thalamus and hypothalamus. Brainstem, cerebellum, and occipital pole not done.
Figure 4
Developmental expression profile of Apba2. Apba2 expression in the primitive neural tube begins by embryonic day 10 
(E10). Expression throughout the neural tube is seen in day E11 and E12, but appears to be restricted to the primitive brain 
vesicles by day E13 and continues during day E14 in all regions of primitive brain, including medulla, midbrain, thalamus, stria-
tum, olfactory lobe, and neopallial cortex as seen above. By day E15, however, Apba2 transcript also appears in the dorsal root 
ganglia surrounding the spinal cord.
A. B.
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ganglia.
The availability of emerging mouse genomic sequence al-
lowed us to examine sequence conservation across the
transcriptional unit. We submitted human and mouse ge-
nomic sequences to the VISTA web site http://www-
gsd.lbl.gov/vista/ and homology is plotted and shown in
Figure 5. Murine genomic sequence for exons 1 and 2 was
not available, and the comparison was made for the re-
mainder of the transcriptional unit. We would expect cod-
ing sequences to be conserved, but regions of non-coding
conservation, which could harbour potential functional
(conserved) sequences, are of particular interest. Several
such regions are present within the APBA2 transcriptional
unit.
Discussion
We have described the mapping of APBA2 to 15q13.1
within a region duplicated in idic(15) marker chromo-
somes, thus clarifying the map position of this gene.
While public and private sequence assemblies now depict
the correct location for this gene, previous published re-
ports indicated that this gene mapped proximal to BP3
within the PWS/AS deletion and autism-associated inter-
stitial duplication interval [21,22]. STS content mapping
with regional clones confirms the predicted genomic as-
semblies and places this gene distal to the BP3 HERC2-
containing breakpoint. Two partial APBA2 copies contain-
ing the first coding exon and downstream sequence and
are located ~5-Mb telomeric in 15q13.3. This location
contains duplicon-like sequences, based on BLAST-detect-
ed homology relationships to other non-overlapping BAC
clones, which contain LCR15-inclusive sequences. This re-
gion may represent yet another functional duplicon. This
suggests the possibility of such sequences upstream from
APBA2, most likely corresponding to BP3 or in a sequence
gap between HERC2 and APBA2. The existence of a dupli-
con-like region near APBA2 would most easily explain the
duplication. The duplicated region corresponded to two
blocks in the intact locus which are joined together in the
duplication copies, perhaps reflecting the original organi-
zation of the intact ancestral locus. Within the 9.7 kb gap
between homology blocks, another low-copy repeat se-
Table 2: PCR primer sequences
Exon Exon Size (bp) Primers Ta (°C) Product Size (bp)
1 117 F 5'-GAGCGTGTGGCCCATCGTT-3' 57 291
R 5'-AGCACATCAGCCCAGACTCATTCA-3'
2 53 F 5'-CATTTTTATACTTGAAGGAGCTCT-3' 50 163
R 5'-GCTGCCTTGTATTTCTTACCTAA-3'
3 991 F 5'-TGTGGGGTTTTGACTCTGTCCTTCC-3' 60 1098
R 5'-GTACCCTGAGGTCCCTTGCTCTCG-3'
4 83 F 5'-CTTTAACTTCCCCGTTTCCAGGTTTG-3' 57 137
R 5'-TCCAGCCCAGAACTCTCATCCTTGAA-3'
5 38 F 5'-GCATATTCAGGTTTTGCATCTTGC-3' 54 185
R 5'-CAGCCCAGAACTCTCATCCTTGAA-3'
6 146 F 5'-CCTGGCTGCCGTGTTCCTTGTG-3' 61 316
R 5'-CGCCATATTCCCTCCTGCTAGTGC-3'
7 34 F 5'-AGACCTGAGAGTGGGGGCATCAAC-3' 57 276
R 5'-TCACCTACCAAGGGAAGAGGAAAAGC-3'
8 88 F 5'-TCTGGTGATTAGGGATGTTGAGCA-3' 55 259
R 5'-ATACCATGGGACAAGAAGGAGTCG-3'
9 189 F 5'-CCACCATGCCCAGCCCTGGAGTAC-3' 64 313
R 5'-GCTGTGAACTTTGGGAGGGGAGTGC-3'
10 179 F 5'-CCTGTGCCACGTGCCTGTCTCCAG-3' 62 253
R 5'-CCTCCCTGAGGCTGGTGGGTGTGG-3'
11 215 F 5'-TCCTCCTGTGGGTCCTTGGCAGAG-3' 64 345
R 5'-GGGGATGAAGTGAGGCAGGGTTGA-3'
12 121 F 5-TAAAGCCCAGCCTGTGACTCCTGTCC-3' 62 251
R 5'-CCAGACATAGCCTGCCCCATTGGA-3'
13 140 F 5'-CTGTCGGGTGTGGCGGGAACACGT-3' 64 275
R 5'-CTCTGGAGCGGGGGAGGCTCATGG-3'
14 1251 F 5'-GCGGCTCAGCCTCCTGTTTCTGTC-3' 62 200
R 5'-CTGTGGCGTCGGGGTCAAGTCTGC-3'
Forward (F) and reverse (R) oligonucleotide sequences are shown along with annealing temperatures (Ta) and PCR product sizePage 7 of 11
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BMC Genomics 2003, 4 http://www.biomedcentral.com/1471-2164/4/15quence of ~1.3 kb was identified. The pattern of partial
duplication seen with APBA2 is similar to that of
CHRNA7. The repetitive nature of this region has present-
ed significant challenges to genomic sequence assembly.
It is likely that repeated elements cause some segments to
be poorly represented in E. coli-based libraries. Our inter-
est in this gene was driven by its plausibility as a candidate
for autism, based upon function. The location of APBA2
outside the narrow deletion/duplication interval makes
this gene less attractive as a candidate for inherited autism.
However, overexpression of this gene in idic(15) cases
could be responsible in part for the increased phenotypic
severity in those cases compared to interstitial
duplication.
We characterized gene structure for the human gene and
expression for both human and mouse genes. There are 14
known exons, 13 of which are shown in the current public
human genomic sequence assemblies. A putative first ex-
on, corresponding to the 5' end of the Celera transcript,
maps at least 74-kb upstream of exon 2. Based on a com-
bination of the public and Celera assemblies, the APBA2
transcriptional unit spans >197 kb. We provided primer
sequences and amplification conditions to facilitate SNP
and disease variant discovery at this locus.
Figure 5
Comparative sequence analysis of human and mouse APBA2 using VISTA. Output from VISTA analysis of the 
ATP10C transcriptional unit is shown, with regions of non-coding sequence conservation (>75% identity) indicated by pink 
shading and coding homology by blue shading. Coding sequence (CDS) is indicated over the transcriptional unit with arrows 
indicating transcriptional orientation. Various repetitive sequences are indicated by shaded boxes over the homology plots.
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BMC Genomics 2003, 4 http://www.biomedcentral.com/1471-2164/4/15APBA2 is expressed throughout the central nervous system
in the adult human and mouse and developing mouse
embryos. The ~4.2-kb predominant transcript is larger
than the longest available mRNA sequence of 3,647 bp.
The difference is most likely due to as yet unidentified 5'
untranslated exons or by use of alternative polyadenyla-
tion sites. The presence of multiple consensus polyade-
nylation signals both before and after the one utilized in
this transcript is consistent with the latter hypothesis. Ad-
ditionally, less abundant smaller transcripts exist. EST
data supports the occurrence of alternative splicing for
this gene. To our knowledge, transcriptional initiation
site(s) have not been characterized for APBA2. The fact
that the partial duplication copies are not expressed sup-
ports the premise that the intact locus may not have a
transcriptional initiation site at exon 3.
Genomic sequence corresponding to the mouse ortholog
is present in the public assembly, although sequence up-
stream of exon 3 is not available. VISTA comparison of
human and mouse sequences reveals several sites of
conserved non-coding sequences; these may contain func-
tional elements necessary for proper expression.
Conclusions
The APBA2 gene maps to 15q13.1 telomeric to HERC2
and BP3. Partial duplications of a 6-kb segment contain-
ing the first coding exon are present as two copies at ~5-
Mb telomeric in 15q13.3 and are not transcribed. The pat-
tern of duplication for APBA2 adds to a complex mosaic
including many duplicon-like structures in 15q13. The
tendency of this region to undergo rearrangement may
bear relation to the evolution of this gene family.
Methods
PCR Analysis of APBA2 Clones and Expression
PCR assays were performed with Roche Taq DNA
polymerase (Indianapolis, IN) in 50 µL reactions for 30
cycles under standard conditions and Ta Of 63°C, using
2.5 mM dNTPs and 0.5 µM primers. Primers: forward 5'-
CAGGAGCCCGAGAGCGAGGA-3'; reverse 5'-GGGTCTC
CGGGGTGCTTGG-3'. Genomic and cDNA sources used
as templates for amplification were obtained from com-
mercial sources: RP-11 BACs from BACPAC Resources
(Oakland, CA), YACs from the Whitehead Institute (Wl)
(Cambridge, MA), and Marathon cDNA from Invitrogen
Life Technologies (Carlsbad, CA). All restriction digests
were performed according to manufacturer recommenda-
tions using enzymes purchased from New England Bi-
olabs (Beverly, MA).
Southern and Northern Blot Analyses
Non-conserved probes corresponding to exon 3 were hy-
bridized to commercially-available Multiple Tissue
Northern blots containing adult human brain polyA+
RNA (Invitrogen Life Technologies, Carlsbad, CA). Blots
were hybridized overnight at 65°C according to manufac-
turer's recommendations and then washed for 2–3 hours
in 2X SSC/0.1% SDS at 65°C. Filters were exposed to Ko-
dak XAR x-ray film (Eastman Kodak; New Haven, CT).
In Situ Hybridization Analysis
Following perfusion, whole brains were obtained from
C57BL/6 mice. Using a Leica CM300 cryostat (Leica,
Wetzler, Germany), frozen brains were sectioned into five
series of 20 mm slices, with individual sections within a
series separated by 100 mm. Wax-embedded embryonic
sections were purchased from Novagen (Madison, Wl). A
probe-containing plasmid was developed for Apba2.
Antisense and sense control cRNA probes were synthe-
sized with the MAXIscript kit using T3, T7, or SP6 RNA
polymerase (Ambion, Austin, TX) in reactions incorporat-
ing α-[33P]-UTP (New England Nuclear Life Science Prod-
ucts, Boston, MA). Purified probes were hybridized to
slides for 20 hours at 58°C and washed in a series of solu-
tions to a final stringency of 0.1 X SSC at 65°C. Hybrid-
ized and washed slides were exposed to BioMax MR film
(Eastman Kodak, New Haven, CT) for varying times,
Table 3: Apba2 in situ hybridization summary
Structure Expression*
Cortex
Frontal (layers II-V) ++
Parietal (layers II-V) ++
Temporal (layers II-V) ++
Piriform (layer II) +++
Cingulate ++
Insular ++
Thalamus
Ant, PV, DM ++
Others +
Hippocampus (CA1, CA2, CA3, DG) +++
Amygdala
Basolateral ++
Other +
Septal Nuclei
Lateral ++
Other +
Habenula
Medial ++
Lateral +
Bed Nucleus of Stria Terminalis Hypothalamus ++
PO, Arc ++
Others +
*Relative expression levels are indicated; +++ corresponds to the 
highest levels of expression and + to the lowest.Page 9 of 11
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pared by scanning film at high resolution.
Sequence Analysis
Direct sequencing from BAC clone template was per-
formed using ABI dye terminator chemistry according to
manufacturer's recommendations (Applied Biosystems,
Foster City, CA). Sequences were purified using spin col-
umns and submitted to the Vanderbilt University Shared
Sequencing Resource. Oligonucleotide primers were de-
signed using Oligo v6.7 (Molecular Biology Insights, Inc.,
Cascade, CO) and MacVector v7.1 (Accelrys, Inc., Burlin-
ton, MA). BLAST comparisons were performed from the
NCBI http://www.ncbi.nlm.nih.gov or EnsembI http://
www.ensembl.org/ websites. Comparative analysis of hu-
man and mouse genomic sequences was performed
through the VISTA web site http://www-gsd.lbl.gov/vista/.
List of abbreviations
PWS, Prader-Willi syndrome
AS, Angelman syndrome
idic(15), pseudodicentric, inverted, duplicated chromo-
somes 15
BP, breakpoint
LCR15, low copy repeats on chromosome 15
STS, sequence-tagged site
EST, expressed sequence tag
YAC, yeast artificial chromosome
BAC, bacterial artificial chromosome
PCR, polymerase chain reaction
RFLP, restriction fragment length polymorphism
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